Cygnus Technologies Email Formats
Biotechnology Research • 
Leland, North Carolina, United States • 51-100 Employees
Cygnus Technologies Email Formats
Cygnus Technologies uses 5 email formats. The most common is {first name} (e.g., john@cygnustechnologies.com), used 30.9% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@cygnustechnologies.com | 30.9% |
{first name}.{last name} | john.doe@cygnustechnologies.com | 26.5% |
{first initial}.{last name} | j.doe@cygnustechnologies.com | 23.5% |
{first name}{last name} | johndoe@cygnustechnologies.com | 7.4% |
{first initial}{last name} | jdoe@cygnustechnologies.com | 5.9% |
Key Contacts at Cygnus Technologies
Jared Isaac
Director, Research And Development
David A. Hylander
Director, Manufacturing Operations
Johnathan Locklear
Associate Director, R&D And Technical Services
David Cetlin
Senior Director, R&D
Marshall Parker
Director Of Quality Operations
Company overview
| Headquarters | 1523 Olde Waterford Way, Leland, NC 28451, US |
| Phone number | +19104549442 |
| Websites | |
| NAICS | 541714 |
| SIC | 511 |
| Keywords | Mass Spectrometry, Viral Clearance, Antibody Affinity Extraction, Host Cell Dna Detection & Extraction Kits, Host Cell Protein Elisa Kits, Process-Specific Hcp Assay Development |
| Founded | 1997 |
| Employees | 51-100 |
| Socials |
About Cygnus Technologies
Cygnus Technologies, part of Maravai LifeSciences, is the biopharmaceutical industry’s partner in host cell protein (HCP) and other process-related impurity detection and analytics. In addition, Cygnus now provides innovative viral clearance solutions as well. Cygnus helps companies developing therapeutic proteins, vaccines, antibodies, plasma derivatives and gene therapies to ensure the safety of biotherapeutics prior to human trials, regulatory approval and commercial release. Cygnus provides analytical tools and solutions delivering insights to improve bioprocess development for faster regulatory approval and better clinical outcomes. Cygnus is an industry pioneer responsible for developing and commercializing the first generic assay kits for HCP detection. Its reputation for quality is recognized by the industry and global regulatory agencies. It continues to advance the science of bioprocess impurity detection with new breakthroughs, including its Antibody Affinity Extraction™ (AAE) technology and orthogonal methods of HCP analysis that integrate Mass Spectrometry, AAE and ELISA. To reduce the cost and risk associated with viral clearance studies, Cygnus also offers a unique approach that utilizes non-infectious mock virus particles through its MockV™ virus clearance kits. Cygnus’ proprietary technology, available through its off-the-shelf and custom analytics programs, sets the gold standard for enabling HCP and other bioprocess impurity antibody assays. Cygnus delivers best-in-class customer service and technical expertise, operational excellence and ISO-9001:2015 certified quality management systems. Founded by Ken Hoffman in 1997, Cygnus continues to support and advance technology in order to improve biotherapeutic safety and accelerate the movement of new therapeutics through the development and regulatory approval process. Located in Southport, North Carolina, Cygnus Technologies is online at www.cygnustechnologies.com.
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Cygnus Technologies has 39 employees across 8 departments.
Departments
Number of employees
Funding Data
Cygnus Technologies has never raised funding before.
Cygnus Technologies Tech Stack
Discover the technologies and tools that power Cygnus Technologies's digital infrastructure, from frameworks to analytics platforms.
Security
JavaScript libraries
UI frameworks
JavaScript frameworks
JavaScript libraries
JavaScript libraries
Maps
Ecommerce
JavaScript libraries
JavaScript libraries
CDN
Austria
France
Taiwan, Province of China
Frequently asked questions
4.8
40,000 users
